SOPHiA GENETICS Releases 2023 ESG Impact Summary
Ticker: SOPH · Form: 6-K · Filed: 2024-06-07T00:00:00.000Z
Sentiment: neutral
Topics: esg, disclosure, sustainability
TL;DR
SOPHIA GENETICS dropped its 2023 ESG report, check investor relations for deets.
AI Summary
SOPHiA GENETICS SA filed a Form 6-K on June 7, 2024, to announce the publication of its Environmental, Social, and Governance (ESG) Impact Summary for the year ended December 31, 2023. The full report is accessible on the company's investor relations website.
Why It Matters
This filing provides stakeholders with insights into SOPHiA GENETICS' commitment to sustainability and corporate responsibility, which can influence investment decisions and company valuation.
Risk Assessment
Risk Level: low — This is a routine disclosure of an ESG report and does not involve new financial transactions or significant operational changes.
Key Players & Entities
- SOPHiA GENETICS SA (company) — Registrant
- December 31, 2023 (date) — Reporting period for ESG Impact Summary
- June 7, 2024 (date) — Filing date
- Daan van Well (person) — Signatory for the filing
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose is to report the publication of SOPHiA GENETICS SA's Environmental, Social, and Governance (ESG) Impact Summary for the year ended December 31, 2023.
Where can investors find the 2023 ESG Impact Summary?
The 2023 ESG Impact Summary is available on www.sophiagenetics.com in the Investor Relations section.
What period does the ESG Impact Summary cover?
The ESG Impact Summary covers the period as per December 31, 2023.
Who signed this Form 6-K on behalf of SOPHiA GENETICS SA?
Daan van Well signed the Form 6-K on behalf of SOPHiA GENETICS SA.
Is SOPHiA GENETICS SA required to file annual reports under Form 20-F or 40-F?
Yes, SOPHiA GENETICS SA indicates it files annual reports under cover of Form 20-F.
Filing Stats: 187 words · 1 min read · ~1 pages · Grade level 11.4 · Accepted 2024-06-07 15:22:38
Filing Documents
- dp212524_6k.htm (6-K) — 10KB
- dp212524_ex9901.htm (EX-99.1) — 22KB
- image_001.jpg (GRAPHIC) — 386KB
- image_002.jpg (GRAPHIC) — 724KB
- image_003.jpg (GRAPHIC) — 481KB
- image_004.jpg (GRAPHIC) — 703KB
- image_005.jpg (GRAPHIC) — 308KB
- 0000950103-24-008063.txt ( ) — 3617KB
From the Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2024. Commission File Number: 001-40627 SOPHiA GENETICS SA (Exact name of registrant as specified in its charter) La Pièce 12 CH-1180 Rolle Switzerland (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F: Form 20-F x Form 40-F SOPHiA GENETICS SA (the “Company”) today published its Environmental, Social and Governance Impact Summary as per December 31, 2023 (“2023 ESG Impact Summary”). The 2023 ESG Impact Summary is available on www.sophiagenetics.com , in the Investor Relations section. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. SOPHiA GENETICS SA Date: June 7, 2024 By: /s/ Daan van Well Name: Daan van Well Title: Chief Legal Officer EXHIBIT INDEX Exhibit No. Description 99.1 2023 ESG Impact Summary